Unravelling mutational signatures with plasma circulating tumour DNA
Details
Publication Year 2024-11-14,Volume 15,Issue #1,Page 9876
Journal Title
Nature Communications
Publication Type
Research article
Abstract
The use of circulating tumour DNA (ctDNA) to profile mutational signatures represents a non-invasive opportunity for understanding cancer mutational processes. Here we present MisMatchFinder, a liquid biopsy approach for mutational signature detection using low-coverage whole-genome sequencing of ctDNA. Through analysis of 375 plasma samples across 9 cancers, we demonstrate that MisMatchFinder accurately infers single-base and doublet-base substitutions, as well as insertions and deletions to enhance the detection of ctDNA and clinically relevant mutational signatures.
Publisher
Springer Nature
Keywords
Humans; *Circulating Tumor DNA/genetics/blood; *Mutation; *Neoplasms/genetics/blood; Liquid Biopsy/methods; Whole Genome Sequencing/methods; DNA Mutational Analysis/methods; Biomarkers, Tumor/genetics/blood; DNA, Neoplasm/genetics/blood
Department(s)
Laboratory Research
Open Access at Publisher's Site
https://doi.org/10.1038/s41467-024-54193-2
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2024-12-12 03:22:38
Last Modified: 2024-12-12 03:29:25
An error has occurred. This application may no longer respond until reloaded. Reload 🗙